Ceribell Inc (NASDAQ: CBLL)’s stock price has plunge by 1.61%relation to previous closing price of $18.63. Nevertheless, the company has seen a -1.87% plunge in its stock price over the last five trading sessions. globenewswire.com reported 2025-05-20 that SUNNYVALE, Calif., May 20, 2025 (GLOBE NEWSWIRE) — CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Jane Chao, Ph.D., CEO and Co-founder, will present at the upcoming William Blair 45th Annual Growth Stock Conference. The presentation will take place on Tuesday, June 3, 2025, at 7:20 a.m. Pacific Standard Time / 9:20 a.m. Central Standard Time.
Is It Worth Investing in Ceribell Inc (NASDAQ: CBLL) Right Now?
Analysts have differing opinions on the stock, with 5 analysts rating it as a “buy”, 1 as “overweight”, 0 as “hold”, and 0 as “sell”.
The public float for CBLL is 20.39M, and currently, short sellers hold a 5.22% ratio of that floaft. The average trading volume of CBLL on July 04, 2025 was 392.61K shares.
CBLL’s Market Performance
CBLL stock saw an increase of -1.87% in the past week, with a monthly gain of 11.81% and a quarterly increase of -1.61%. The volatility ratio for the week is 3.71%, and the volatility levels for the last 30 days are 3.85% for Ceribell Inc (CBLL). The simple moving average for the past 20 days is 3.64% for CBLL’s stock, with a -13.70% simple moving average for the past 200 days.
Analysts’ Opinion of CBLL
Many brokerage firms have already submitted their reports for CBLL stocks, with BTIG Research repeating the rating for CBLL by listing it as a “Buy”. The predicted price for CBLL in the upcoming period, according to BTIG Research is $30 based on the research report published on June 24, 2025 of the current year 2025.
Ladenburg Thalmann, on the other hand, stated in their research note that they expect to see CBLL reach a price target of $32. The rating they have provided for CBLL stocks is “Buy” according to the report published on April 04th, 2025.
TD Cowen gave a rating of “Buy” to CBLL, setting the target price at $31 in the report published on November 05th of the previous year.
CBLL Trading at 9.27% from the 50-Day Moving Average
After a stumble in the market that brought CBLL to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -42.20% of loss for the given period.
Volatility was left at 3.85%, however, over the last 30 days, the volatility rate increased by 3.71%, as shares surge +10.44% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +28.17% upper at present.
During the last 5 trading sessions, CBLL fell by -1.87%, in comparison to the 20-day moving average, which settled at $18.27. In addition, Ceribell Inc saw N/A in overturn over a single year, with a tendency to cut further N/A.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CBLL starting from ROBERTSON REBECCA B, who sold 11,188 shares at the price of $17.85 back on Jun 18 ’25. After this action, ROBERTSON REBECCA B now owns 10,042 shares of Ceribell Inc, valued at $199,706 using the latest closing price.
ROBERTSON REBECCA B, the Director of Ceribell Inc, sale 7,445 shares at $17.63 during a trade that took place back on Jun 17 ’25, which means that ROBERTSON REBECCA B is holding 21,230 shares at $131,255 based on the most recent closing price.
Stock Fundamentals for CBLL
Current profitability levels for the company are sitting at:
- -0.64% for the present operating margin
- 0.87% for the gross margin
The net margin for Ceribell Inc stands at -0.63%. The total capital return value is set at -0.23%.
Based on Ceribell Inc (CBLL), the company’s capital structure generated 0.11 points at debt to capital in total, while cash flow to debt ratio is standing at -1.75. The debt to equity ratio resting at 0.12. The interest coverage ratio of the stock is -81.49.
Currently, EBITDA for the company is -37.71 million with net debt to EBITDA at 3.01. When we switch over and look at the enterprise to sales, we see a ratio of 7.77. The receivables turnover for the company is 6.29for trailing twelve months and the total asset turnover is 0.33. The liquidity ratio also appears to be rather interesting for investors as it stands at 17.19.
Conclusion
In a nutshell, Ceribell Inc (CBLL) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
